Robust and clinically relevant prediction of response to anti-cancer drugs via network integration of molecular profiles
M. Franco, A. Jeggari, S. Peuget, F. Böttger, G. Selivanova, A. Alexeyenko
The paper introduces NEAmarker, a method for pathway-level biomarker discovery that outperforms existing methods in cross-platform integration, consistency, and survival prediction.
bioRxiv · Aug 21, 2018Cancer Biology